Ardelyx Sets Transition Compensation Terms for Departing Chief Legal and Administrative Officer

Reuters
2025/12/18
<a href="https://laohu8.com/S/ARDX">Ardelyx</a> Sets Transition Compensation Terms for Departing Chief Legal and Administrative Officer

Ardelyx Inc. has announced a Transition and Separation Agreement with Elizabeth Grammer following her resignation as Chief Legal and Administrative Officer, effective December 31, 2025. Under the agreement, Grammer will continue as General Counsel until a successor is appointed, then serve as Senior Advisor for 24 months. During her continued employment and the first 12 months of her advisory period, she will receive her current base salary and be eligible for her 2025 annual target bonus of 45% of her base salary. At the end of this period, she will be paid an additional amount equal to one month of her base salary, contingent on a release of claims. For the second 12 months of the advisory period, her equity will continue to vest, and she will be eligible for an advisory payment during the first nine months of this phase. Ardelyx will also cover COBRA health insurance premiums for Grammer and her dependents throughout the advisory period or until she receives coverage from another employer.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ardelyx Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437402-25-000021), on December 17, 2025, and is solely responsible for the information contained therein.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10